Share:
Bill Information
Regular Session 2019-2020
Senate Bill 675
Short Title:
An Act providing for certification of buprenorphine office-based prescribers; limiting the use of buprenorphine; and imposing powers and duties on the Department of Drug and Alcohol Programs.
Prime Sponsor:
Last Action:
Referred to HUMAN SERVICES, June 18, 2019 [House]
Printer's No.:
| Printer's No. | Text | (H) Amendments | (S) Amendments | (H) Fiscal Note | (S) Fiscal Note | Actuarial Note |
|---|---|---|---|---|---|---|
| 820* |
* denotes current Printer's Number